Urbonavicius, S., Srinanthalogen, R., Sandermann, J., Valius, M., Kaupinis, A.
& Ludvigsen, M. (2024).
A novel view to varicose veins pathogenesis: Proteomic profiling suggests a pivotal role of extracellular matrix degradation.
Phlebology,
39(1), 20-28.
https://doi.org/10.1177/02683555231206891
Rosenberg, C. A., Rodrigues, M. A.
, Bill, M. & Ludvigsen, M. (2024).
Author Correction: Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data (Scientific Reports, (2024), 14, 1, (9349), 10.1038/s41598-024-59875-x).
Scientific Reports,
14(1), Article 13024.
https://doi.org/10.1038/s41598-024-63712-6
Hybel, T. E., Sørensen, E. F., Enemark, M. H., Hemmingsen, J. K., Simonsen, A. T., Lauridsen, K. L., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S., d'Amore, F., Hamilton-Dutoit, S., Stougaard, M., Vase, M. Ø. & Ludvigsen, M. (2024).
Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.
AIDS,
38(14), 1897-1906.
https://doi.org/10.1097/QAD.0000000000003996
Shelton, V., Detroja, R., Liu, T., Isaev, K., Silva, A., Passerini, V., Bakhtiari, M., Calvente, L., Hong, M., He, M. Y., Modi, S., Hershenfeld, S. A.
, Ludvigsen, M., Madsen, C., Hamilton-Dutoit, S., d’Amore, F. A., Brodtkorb, M., Johnson, N. A., Baetz, T. ... Kridel, R. (2024).
Identification of genetic subtypes in follicular lymphoma.
Blood Cancer Journal,
14(1), Article 128.
https://doi.org/10.1038/s41408-024-01111-wHybel, T. E., Jensen, S. H., Rodrigues, M. A.
, Hybel, T. E., Pedersen, M. N., Qvick, S. H.
, Enemark, M. H., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2024).
Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia.
International Journal of Molecular Sciences ,
25(12), Article 6465.
https://doi.org/10.3390/ijms25126465
Enemark, M. H.
, Jensen, M. L., Andersen, M. D., Plesner, T. L., Hamilton-Dutoit, S. & Ludvigsen, M. (2024).
Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab Era.
Cancers,
16(20), Article 3553.
https://doi.org/10.3390/cancers16203553Fischer, A., Albert, T. K., Moreno, N., Interlandi, M., Mormann, J., Glaser, S., Patil, P., de Faria, F. W., Richter, M., Verma, A., Balbach, S. T., Wagener, R., Bens, S., Dahlum, S., Göbel, C., Münter, D., Inserte, C., Graf, M., Kremer, E. ... Kerl, K. (2024).
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.
Nature Communications,
15(1), 8571. Article 8571.
https://doi.org/10.1038/s41467-024-52826-0Enemark, M. H., Hemmingsen, J. K., Jensen, M. L., Kridel, R.
& Ludvigsen, M. (2024).
Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review.
International Journal of Molecular Sciences ,
25(20), Article 11179.
https://doi.org/10.3390/ijms252011179
Dupuis, J., Bachy, E., Morschhauser, F., Cartron, G., Fukuhara, N., Daguindau, N., Casasnovas, R. O., Snauwaert, S., Gressin, R., Fox, C. P.
, d'Amore, F. A., Staber, P. B., Tournilhac, O., Bouabdallah, K., Thieblemont, C., André, M., Rai, S., Ennishi, D., Gkasiamis, A. ... Lemonnier, F. (2024).
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
The Lancet Haematology,
11(6), e406-e414.
https://doi.org/10.1016/S2352-3026(24)00102-9Bencardino, M.
, D'Amore, F., Angot, H., Angiuli, L., Bertrand, Y., Cairns, W., Diéguez, M. C., Dommergue, A., Ebinghaus, R., Esposito, G., Komínková, K., Labuschagne, C., Mannarino, V., Martin, L., Martino, M., Neves, L. M., Mashyanov, N., Magand, O., Nelson, P. ... Pirrone, N. (2024).
Patterns and trends of atmospheric mercury in the GMOS network: Insights based on a decade of measurements.
Environmental Pollution,
363, Article 125104.
https://doi.org/10.1016/j.envpol.2024.125104Enemark, M. H., Hemmingsen, J. K., Andersen, M. D., Hybel, T. E., Bjørn, M. E., Josefsson, P. L., Pedersen, L. M., Juul, M. B.
, Pedersen, R. S., Thorsgaard, M.
, Sillesen, I. B., Plesner, T. L.
, Hamilton-Dutoit, S. J., Jensen, P.
, Madsen, C. & Ludvigsen, M. (2024).
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.
Blood Cancer Journal,
14(1), 167. Article 167.
https://doi.org/10.1038/s41408-024-01150-3
Hemmingsen, J. K., Enemark, M. H., Sørensen, E. F., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R.
, Honoré, B. & Ludvigsen, M. (2024).
Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma.
Cancers,
16(19), Article 3278.
https://doi.org/10.3390/cancers16193278
Ludvigsen, L. U. P., Andersen, A. S.
, Hamilton-Dutoit, S., Jensen-Fangel, S., Bøttger, P., Handberg, K. J., Ivarsen, P., d'Amore, F., Bibby, B. M., Albertsen, B. K., Jespersen, B. & Thomsen, M. K. (2023).
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.
Journal of Clinical Virology,
167, Article 105579.
https://doi.org/10.1016/j.jcv.2023.105579
Leivonen, S. K., Friman, T., Autio, M., Vaittinen, S., Jensen, A. W.
, d’Amore, F., Hamilton-Dutoit, S. J., Holte, H., Beiske, K., Kovanen, P. E., Räty, R. & Leppä, S. (2023).
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.
Haematologica,
108(11), 3044-3057.
https://doi.org/10.3324/haematol.2023.282831Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z., Bak, R. O., Holm, K., Sorensen, B., Nyegaard, M., Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023).
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
Leukemia,
37(9), 1792-1801.
https://doi.org/10.1038/s41375-023-01950-9
Enemark, M. B. H., Sørensen, E. F., Hybel, T. E., Andersen, M. D., Madsen, C., Lauridsen, K. L., Honoré, B., d'Amore, F., Plesner, T. L.
, Hamilton-Dutoit, S. J. & Ludvigsen, M. (2023).
IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients.
International Journal of Molecular Sciences ,
24(8), Article 7314.
https://doi.org/10.3390/ijms24087314
Beck Enemark, M., Wolter, K., Campbell, A. J.
, Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C., Lauridsen, K. L., Plesner, T. L., Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023).
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
Blood Advances,
7(24), 7418-7432.
https://doi.org/10.1182/bloodadvances.2023011299
Ludvigsen, M., Campbell, A. J.
, Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K.
, Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S.
, Jørgensen, J. M. & Honoré, B. (2023).
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.
Blood Cancer Journal,
13(1), Article 161.
https://doi.org/10.1038/s41408-023-00931-6
Antiga, E.
, Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A.
, D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M. ... Marzano, A. V. (2023).
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Journal of the European Academy of Dermatology & Venereology,
37(6), 1118-1134.
https://doi.org/10.1111/jdv.18931Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G.
, Hamilton-Dutoit, S., Obel, N.
, Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022).
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia and Lymphoma,
63(6), 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741
Honoré, B., Andersen, M. D., Wilken, D., Kamper, P., d'Amore, F., Hamilton-Dutoit, S. & Ludvigsen, M. (2022).
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
Cancers,
14(1), Article 247.
https://doi.org/10.3390/cancers14010247
Soerensen, J. F., Aggerholm, A., Rosenberg, C. A., Bill, M., Kerndrup, G. B.
, Ebbesen, L. H., Hansen, M. H., Roug, A. S. & Ludvigsen, M. (2022).
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Bone Marrow Transplantation,
57(3), 460-465.
https://doi.org/10.1038/s41409-022-01567-z
Herek, T. A., Bouska, A., Lone, W., Sharma, S., Amador, C., Heavican, T. B., Li, Y., Wei, Q., Jochum, D., Greiner, T. C., Smith, L., Pileri, S., Feldman, A. L., Rosenwald, A., Ott, G., Lim, S. T., Ong, C. K., Song, J., Jaffe, E. S. ... Iqbal, J. (2022).
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood,
140(11), 1278-1290.
https://doi.org/10.1182/blood.2021015019de Leval, L., Alizadeh, A. A., Bergsagel, P. L., Campo, E., Davies, A., Dogan, A., Fitzgibbon, J., Horwitz, S. M., Melnick, A. M., Morice, W. G., Morin, R. D., Nadel, B., Pileri, S. A., Rosenquist, R., Rossi, D., Salaverria, I., Steidl, C., Treon, S. P., Zelenetz, A. D. ... Scott, D. W. (2022).
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood,
140(21), 2193-2227.
https://doi.org/10.1182/blood.2022015854Hussmann, D., Starnawska, A., Kristensen, L.
, Daugaard, I., Thomsen, A.
, Kjeldsen, T., Hansen, C. S., Bybjerg-Grauholm, J.
, Dalsgaard Johansen, K., Ludvigsen, M., Kristensen, T., Larsen, T. S., Møller, M. B., Nyvold, C. G.
, Hansen, L. L. & Wojdacz, T. K. (2022).
IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.
Haematologica,
107(4), 877-886.
https://doi.org/10.3324/haematol.2021.278477
Rosenberg, C. A., Bill, M., Maguire, O.
, Petersen, M. A., Kjeldsen, E., Hokland, P. & Ludvigsen, M. (2022).
Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry.
Cytometry. Part B: Clinical Cytometry,
102(2), 107-114.
https://doi.org/10.1002/cyto.b.22035
Petersen, M. A., Rosenberg, C. A., Brøndum, R. F.
, Aggerholm, A., Kjeldsen, E., Rahbek, O.
, Ludvigsen, M., Hasle, H., Roug, A. S. & Bill, M. (2022).
Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
British Journal of Haematology,
197(4), 452-466.
https://doi.org/10.1111/bjh.18094
Andersen, M. I. D., Hamilton-Dutoit, S., Modvig, L.
, Vase, M., Christiansen, I., Christensen, J. H., Dahl-Sørensen, R. B., Stoltenberg, D.
, Kamper, P. & d'Amore, F. (2022).
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma: A study from the Danish Lymphoma Registry.
British Journal of Haematology,
198(1), 50-61.
https://doi.org/10.1111/bjh.18180
Relander, T.
, Pedersen, M. B., Ellin, F., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Holte, H., Österborg, A., Nully Brown, P. D., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Delabie, J., Sundström, C., Sander, B.
, Hamilton-Dutoit, S. J., Ehinger, M., Liestøl, K.
... d'Amore, F. A. (2022).
Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial.
Blood,
140(Supplement 1), 1479–1480.
https://doi.org/10.1182Petersen, M. A., Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O.
, Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022).
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.
Cancers,
14(15), Article 3567.
https://doi.org/10.3390/cancers14153567
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., Dogan, A., Feldman, A. L., Fend, F., Friedberg, J. W., Gaulard, P., Ghia, P., Horwitz, S. M., King, R. L., Salles, G. ... Zelenetz, A. D. (2022).
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood,
140(11), 1229-1253.
https://doi.org/10.1182/blood.2022015851Enemark, M. B., Hybel, T. E., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’amore, F. & Ludvigsen, M. (2022).
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.
Cancers,
14(5), Article 1316.
https://doi.org/10.3390/cancers14051316
Wulf, G. G., Altmann, B., Ziepert, M.
, D’Amore, F., Held, G., Greil, R., Tournilhac, O., Relander, T., Viardot, A., Wilhelm, M., Wilhelm, C., Pezzutto, A., Zijlstra, J. M., Neste, E. V. D., Lugtenburg, P. J., Doorduijn, J. K., Gelder, M. V., van Imhoff, G. W., Zettl, F. ... ACT-2 study investigators (2021).
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Leukemia,
35(1), 143-155.
https://doi.org/10.1038/s41375-020-0838-5Holst, J. M., Enemark, M. B., Plesner, T. L.
, Pedersen, M. B., Ludvigsen, M. & d'Amore, F. (2021).
Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Case Reports in Hematology,
2021, Article 6623706.
https://doi.org/10.1155/2021/6623706
Rosenberg, C. A., Bill, M., Rodrigues, M. A.
, Hauerslev, M., Kerndrup, G. B.
, Hokland, P. & Ludvigsen, M. (2021).
Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Cytometry. Part B: Clinical Cytometry,
100(5), 554-567.
https://doi.org/10.1002/cyto.b.21975
Hybel, T. E., Vase, M. Ø., Maksten, E. F.
, Enemark, M. B., Lauridsen, K. L., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, d'Amore, F. & Ludvigsen, M. (2021).
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.
Acta Oncologica,
60(12), 1637-1642.
https://doi.org/10.1080/0284186X.2021.1973093
Beck Enemark, M., Monrad, I., Madsen, C., Lystlund Lauridsen, K., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021).
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
OncoTargets and Therapy,
14, 481-489.
https://doi.org/10.2147/OTT.S289337
Vajavaara, H., Ekeblad, F., Holte, H.
, Jorgensen, J., Leivonen, S.-K., Berglund, M.
, Kamper, P., Moller, H. J., D'Amore, F., Molin, D., Enblad, G.
, Ludvigsen, M., Glimelius, I. & Leppa, S. (2021).
Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma.
Haematologica,
106(9), 2502-2506.
https://doi.org/10.3324/haematol.2020.278182Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2021).
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
Current issues in molecular biology,
43(2), 1043-1056.
https://doi.org/10.3390/cimb43020074
Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R., Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L.
, Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021).
Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia.
Cancers,
13(21), Article 5526.
https://doi.org/10.3390/cancers13215526
Vajavaara, H.
, Mortensen, J. B., Leivonen, S.-K.
, Hansen, I. M., Ludvigsen, M., Holte, H.
, Jørgensen, J., Bjerre, M., d'Amore, F. & Leppä, S. (2021).
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma.
Cancers,
13(3), Article 398.
https://doi.org/10.3390/cancers13030398Mortensen, J. B., Monrad, I., Enemark, M. B., Ludvigsen, M., Kamper, P., Bjerre, M. & d'Amore, F. (2021).
Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
European Journal of Haematology,
107(1), 81-91.
https://doi.org/10.1111/ejh.13621
Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T.
, Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020).
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Blood,
136(24), 2754-2763.
https://doi.org/10.1182/blood.2020007247